Get a Quote

VALGANCICLOVIR HYDROCHLORIDE
CAS NO.: 175865-59-5
Chemical Formula: C14H22N6O5•HCl
Molecular Weight: 390.8200
DMF&GMP status: Please contact us for more details.
Description:
VALGANCICLOVIR HYDROCHLORIDE API | CAS 175865-59-5 | Genegobio | Valganciclovir is an antiviral drug. It works by preventing viral cells from multiplying in your body.Valganciclovir is used in adults to prevent infection with cytomegalovirus (CMV) that may occur after an organ transplant (heart, kidney, or pancreas). Valganciclovir is also used to treat CMV infection of the eye in adults with acquired immunodeficiency syndrome (AIDS).Valganciclovir is used in children at least 4 months old to prevent CMV infection after a kidney transplant. Valganciclovir is also used in children at least 1 month old to prevent CMV disease after a heart transplant.Valganciclovir will not cure CMV but it can help control the infection. Valganciclovir is not for treating CMV that a baby is born with.
Approvals
Active Ingredient Dosage Form; Route Strength Proprietary Name Applicant
VALGANCICLOVIR HYDROCHLORIDEFOR SOLUTION; ORAL50MG/MLVALCYTEHOFFMANN LA ROCHE
VALGANCICLOVIR HYDROCHLORIDE TABLET; ORAL EQ 450MG BASE VALCYTE HOFFMANN LA ROCHE
VALGANCICLOVIR HYDROCHLORIDE TABLET; ORAL EQ 450MG BASE VALGANCICLOVIR HYDROCHLORIDE AUROBINDO PHARMA LTD
VALGANCICLOVIR HYDROCHLORIDE TABLET; ORAL EQ 450MG BASE VALGANCICLOVIR HYDROCHLORIDE DR REDDYS LABS LTD
VALGANCICLOVIR HYDROCHLORIDE TABLET; ORAL EQ 450MG BASE VALGANCICLOVIR HYDROCHLORIDE ENDO PHARMS INC
VALGANCICLOVIR HYDROCHLORIDE TABLET; ORAL EQ 450MG BASE VALGANCICLOVIR HYDROCHLORIDE HETERO LABS LTD V
Patent Data
Patent No. Patent Expiration Drug Substance Claim Drug Product Claim Patent Use Code
Exclusive Data
Exclusivity Code Exclusivity Expiration
NPP 23-Apr-18
D - 148 23-Apr-18